Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

¹⁸F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis.

Mandry D, Tatopoulos A, Chevalier-Mathias E, Lemarié J, Bollaert PE, Roch V, Olivier P, Marie PY, Gibot S.

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1924-30. doi: 10.1007/s00259-014-2804-9. Epub 2014 May 22.

PMID:
24848788
2.

Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.

Kluge S, Braune S, Nierhaus A, Wichmann D, Derlin T, Mester J, Klutmann S.

J Crit Care. 2012 Jun;27(3):316.e1-7. doi: 10.1016/j.jcrc.2011.10.004. Epub 2011 Dec 15.

PMID:
22176803
3.

Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study.

Cautela J, Alessandrini S, Cammilleri S, Giorgi R, Richet H, Casalta JP, Habib G, Raoult D, Mundler O, Deharo JC.

Europace. 2013 Feb;15(2):252-7. doi: 10.1093/europace/eus335. Epub 2012 Nov 12.

4.

F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection.

Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG.

Intensive Care Med. 2010 Mar;36(3):504-11. doi: 10.1007/s00134-009-1697-8. Epub 2009 Oct 22.

5.

[18F-FDG PET in the diagnosis of large vessel vasculitis].

Rehák Z, Fojtík Z, Stanícek J, Bolcák K, Frysáková L.

Vnitr Lek. 2006 Nov;52(11):1037-44. Czech.

PMID:
17165522
6.

Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study.

Pepe G, Rossetti C, Sironi S, Landoni C, Gianolli L, Pastorino U, Zannini P, Mezzetti M, Grimaldi A, Galli L, Messa C, Fazio F.

Nucl Med Commun. 2005 Sep;26(9):831-7.

PMID:
16096588
7.

[F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan].

Ruiz Franco-Baux JV, Borrego Dorado I, Gómez Camarero P, Rodríguez Rodríguez JR, Vázquez Albertino RJ, Navarro González E, Astorga Jiménez R.

Rev Esp Med Nucl. 2005 Jan-Feb;24(1):5-13. Spanish.

8.

Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.

Wang G, Wu Y, Zhang W, Li J, Wu P, Xie C.

J Med Imaging Radiat Oncol. 2013 Feb;57(1):65-71. doi: 10.1111/j.1754-9485.2012.02441.x. Epub 2012 Oct 17.

PMID:
23374557
9.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
10.

Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.

Povoski SP, Hall NC, Murrey DA Jr, Chow AZ, Gaglani JR, Bahnson EE, Mojzisik CM, Kuhrt MP, Hitchcock CL, Knopp MV, Martin EW Jr.

World J Surg Oncol. 2011 Nov 23;9:152. doi: 10.1186/1477-7819-9-152.

11.

Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.

Dumarey N, Egrise D, Blocklet D, Stallenberg B, Remmelink M, del Marmol V, Van Simaeys G, Jacobs F, Goldman S.

J Nucl Med. 2006 Apr;47(4):625-32.

12.
13.

Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.

Kawata S, Imaizumi M, Kako Y, Oku N.

Ann Nucl Med. 2014 May;28(4):322-8. doi: 10.1007/s12149-014-0814-0. Epub 2014 Feb 1.

PMID:
24488705
14.

Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.

Ann Surg Oncol. 2008 Jan;15(1):286-92. Epub 2007 Sep 20.

PMID:
17882493
15.

Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin.

Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B.

Int J Infect Dis. 2014 Feb;19:53-8. doi: 10.1016/j.ijid.2013.10.009. Epub 2013 Dec 1.

16.

The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.

Alzahrani AS, Abouzied ME, Salam SA, Mohamed G, Rifai A, Al Sugair A, Amin T.

Eur J Endocrinol. 2008 May;158(5):683-9. doi: 10.1530/EJE-07-0903. Erratum in: Eur J Endocrinol. 2008 Jun 1;158(6):941. Al-Zahrani, Ali S [corrected to Alzahrani, Ali S].

17.

Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.

Hot A, Maunoury C, Poiree S, Lanternier F, Viard JP, Loulergue P, Coignard H, Bougnoux ME, Suarez F, Rubio MT, Mahlaoui N, Dupont B, Lecuit M, Faraggi M, Lortholary O.

Clin Microbiol Infect. 2011 Mar;17(3):409-17. doi: 10.1111/j.1469-0691.2010.03301.x.

18.

Modest utility of quantitative measures in (18)F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection.

Saleem BR, Berger P, Vaartjes I, de Keizer B, Vonken EJ, Slart RH, de Borst GJ, Zeebregts CJ.

J Vasc Surg. 2015 Apr;61(4):965-71. doi: 10.1016/j.jvs.2014.11.005. Epub 2014 Dec 10.

PMID:
25498161
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk